Prevention of heart failure progression: current approaches

被引:0
|
作者
Lechat, P [1 ]
机构
[1] Pitie Salpetriere Hosp, Dept Pharmacol, F-7513 Paris, France
关键词
heart failure; compensatory mechanisms; sympathetic nervous system; renin-angiotensin-aldosterone system; diuretics; ACE inhibitors; alpha- and beta-adrenergic blockers;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure results from damage and stress to the myocardium whatever the aetiology. An increase in stress by cardiac overload is initially overcome by compensatory mechanisms that maintain blood pressure through a combination of the sympathetic nervous system and the renin-angiotensin-aldosterone system. These mechanisms may also alter myocyte function and induce progressive cell death and replacement by fibrous tissue. Disease therapy must reduce cardiac loading and avoid blood pressure control by mechanisms that have deleterious effects. Therapy includes diuretics, vasodilators and alpha-and beta-adrenergic blockade. Complete blockade of all receptors involved in the adverse effects of neurohormonal stimulation might represent an ultimate therapy objective, and improve subsequent prognosis. Large clinical trials are in progress to determine the therapy of choice in the prevention of progression of heart failure.
引用
收藏
页码:B12 / B18
页数:7
相关论文
共 50 条
  • [21] State of the art: current treatment of heart failure
    Hess, OM
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2000, 2 (0A) : A13 - A16
  • [22] Contemporary approaches to diagnosis and management of chronic heart failure (summary of the American College of Cardiology/American Heart Association Guidelines)
    Sidorenko, BA
    Preobrazhensky, DV
    Batyraliev, TA
    Marenitch, AV
    Romanova, NE
    KARDIOLOGIYA, 2002, 42 (06) : 65 - 78
  • [23] Current Clinical and Pharmacological Approaches to the Prescription of Loop Diuretics in Patients with Chronic Heart Failure
    Gafurova, Nupaysat M.
    Shikh, Evgenia, V
    Ostroumova, Olga D.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2020, 16 (04) : 595 - 600
  • [24] The progression from hypertension to heart failure
    Deedwania, PC
    AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (10) : S280 - S288
  • [25] A Mitochondrial Basis for Heart Failure Progression
    Watson, William D.
    Arvidsson, Per M.
    Miller, Jack J. J.
    Lewis, Andrew J.
    Rider, Oliver J.
    CARDIOVASCULAR DRUGS AND THERAPY, 2024, : 1161 - 1171
  • [26] Metabolic disorder in the progression of heart failure
    Xiuxiu Zhang
    Huiying Liu
    Juan Gao
    Min Zhu
    Yupeng Wang
    Changtao Jiang
    Ming Xu
    Science China(Life Sciences), 2019, (09) : 1153 - 1167
  • [27] Metabolic disorder in the progression of heart failure
    Zhang, Xiuxiu
    Liu, Huiying
    Gao, Juan
    Zhu, Min
    Wang, Yupeng
    Jiang, Changtao
    Xu, Ming
    SCIENCE CHINA-LIFE SCIENCES, 2019, 62 (09) : 1153 - 1167
  • [28] NEUROHORMONAL SYSTEMS DURING PROGRESSION OF HEART-FAILURE - A REVIEW
    SVANEGAARD, J
    JOHANSEN, JB
    THAYSSEN, P
    HAGHFELT, T
    CARDIOLOGY, 1993, 83 (1-2) : 21 - 29
  • [29] Progression and management of chronic heart failure
    Viganego, F.
    Le Jemtel, T. H.
    PANMINERVA MEDICA, 2007, 49 (03) : 109 - 118
  • [30] Metabolic disorder in the progression of heart failure
    Xiuxiu Zhang
    Huiying Liu
    Juan Gao
    Min Zhu
    Yupeng Wang
    Changtao Jiang
    Ming Xu
    Science China Life Sciences, 2019, 62 : 1153 - 1167